/PRNewswire/ The drug atogepant may help prevent migraines for people who have had no success with other preventive drugs, according to a preliminary study.
According to a study, the medicine atogepant may help prevent migraines for those who have had little success with existing preventive drugs. The findings will be presented at the American Academy of Neurology's 75th Annual Meeting, which will be held in person in Boston and live online from April 22-27, 2023. The study included patients who had episodic migraine, which is characterised as having up to 14 headache days per month with migraine symptoms.
The drug atogepant may help prevent migraines for people who have had no success with other preventive drugs, according to a preliminary study released April 20, 2023, which will be presented at the American Academy of Neurology's 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.